Orexo US Blog Contact EN About Us Key Therapeutic Areas Pharmaceuticals Digital Therapies Sustainability Investors Media OREXO INVESTORS Investor Relations Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY). Share price Orexo 36.88 1.24 SEK (3.48%) 17:29 CET • 2021-11-26 Financial calendar & events Stora Aktiedagen Stockholm, Sweden NOVEMBER 29, 2021 Pharma Network Breakfast Seminar Pharma & Digital Health DECEMBER 7, 2021 JP Morgan 40th Annual Healthcare Conference JANUARY 10, 2022 LATEST FINANCIAL REPORT Interim Report Q3 2021, Nov. 3 PDF | AudioCast | Presentation Read ESG form SHORTCUT Latest presentations SHORTCUT Analyst reports EXPLORE Investment thesis EXPLORE Latest CEO Comments NOVEMBER 3, 2021 "Steady progression on our journey to build a broader and stronger Orexo" Read the latest CEO comments from Nikolaj Sørensen GO TO CEO SECTION READ THE ANNUAL REPORT 2020 ALSO INCL. THE SUSTAINABILITY REPORT News flow Regulatory Press Releases Orexo announces positive results from pivotal trial for its leading pharmaceutical pipeline asset OX124 16 November 2021 · Press Release · Regulatory Orexo Q3 2021 Interim Report 3 November 2021 · Report · Regulatory Orexo Q2 2021 Interim Report 15 July 2021 · Report · Regulatory Orexo Q1 2021 Interim Report 29 April 2021 · Report · Regulatory Press Releases and News Orexo provides information about its new proprietary drug delivery platform – amorphOX™ 26 November 2021 · Press Release Orexo´s Nomination Committee for the Annual General Meeting 2022 1 November 2021 · Press Release Invitation to presentation of Orexo´s Q3 Interim Report, on November 3 at 1 pm CET 22 October 2021 · Invitation MODIA™ paper published in the Journal of Medical Internet Research Mental Health 18 October 2021 · Press Release IR-CONTACT Lena Wange IR & Communications Director +46 (0)73 064 16 36 ir@orexo.com Subscription Pressrelease Report Annual Financial Statement Interim Report Invitation News English Swedish Name Email When you sign up to our newsletter or press releases, we use the data necessary for this purpose, or the data separately provided by you, to send you our email regularly. You can unsubscribe from our newsletter or press releases at any time via a link provided in the email Thanks and welcome back! ©2021 Orexo AB (publ.) – All rights reserved Contact | Dictionary & Definitions | Privacy Policy | Legal notice | Cookie policy